美股異動|名創優品盤前升近4% 堅定發展IP聯名和品牌出海兩大方向獲中金看好
名創優品(MNSO.US)盤前升3.81%報19.05美元。中金髮報吿指,該行參加了名創優品舉辦的2024全球品牌戰略升級成果發佈會,並對10月新開的上海MINISO LAND門店進行了調研,門店客流如鯽,哈利波特IP銷售火爆。該行指公司堅定發展IP聯名和品牌出海兩大方向,維持對其今明兩年每股盈測2.15及2.59元人民幣不變;考慮四季度進入旺季催化估值提升,上調H股目標價9%至44.6港元,對應預測今明兩年non-IFRS市盈率18及15倍。(格隆匯)

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.